Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
RESEARCH TOOLSreports
ARVN Analyst Ratings
Strong Buy
16 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ARVN Stock 12 Month Forecast
Average Price Target
$63.64
▲(246.43% Upside)
| Highest Price Target$110.00 | Average Price Target$63.64 | Lowest Price Target$32.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BMO Capital
Reiterated
02/12/25
Truist Financial
Reiterated
02/12/25
Stifel Nicolaus
Reiterated
02/12/25
Barclays
Reiterated
02/12/25
Oppenheimer
Reiterated
02/12/25
Guggenheim
Reiterated
02/11/25
Wells Fargo
Reiterated
02/11/25
H.C. Wainwright
Reiterated
02/11/25
Bank of America Securities
Reiterated
02/11/25
BTIG
$69
Buy
275.61%
Upside
Reiterated
02/11/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (NYSE: MDT), Biohaven Ltd. (NYSE: BHVN) and Arvinas Holding Company (NASDAQ: ARVN)
TD Cowen
―
Buy
―
Reiterated
02/11/25
Positive Outlook for Arvinas' Vepdeg and Strategic Expansion Justifies Buy RatingWe note that Eli Lilly presented the EMBER-3 data at SABCS 2024 that demonstrated stat sig benefit for imlunestrant monotherapy vs. fulvestrant in ESR1m patients (5.5 vs. 3.8 month mPFS), but with no significant benefit in all patients (ESR1m and wildtype). Additionally, EMBER-3 patients were less pretreated than VERITAC-2 patients, which needs to be taken into account.
Leerink Partners
$49
Buy
166.74%
Upside
Reiterated
02/11/25
Arvinas Holding Company: Strategic Advancements and Strong Financial Position Drive 'Buy' Rating
Evercore ISI
$110
Buy
498.80%
Upside
Assigned
12/11/24
Arvinas Holding Company (ARVN) Receives a Buy from Evercore ISI
Piper Sandler
$67
Buy
264.73%
Upside
Reiterated
12/04/24
Piper Sandler Keeps Their Buy Rating on Arvinas Holding Company (ARVN)
Best Analysts Covering Arvinas Holding Company
Which Analyst Should I Follow If I Want to Buy ARVN and Sell After:
1 Month
xxx
Success Rate
5/9 ratings generated profit
Average Return
+8.68%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +8.68% per trade.
3 Months
xxx
Success Rate
6/9 ratings generated profit
Average Return
+17.67%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +17.67% per trade.
1 Year
Success Rate
6/9 ratings generated profit
Average Return
+4.06%
reiterated a buy rating 11 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +4.06% per trade.
2 Years
xxx
Success Rate
5/13 ratings generated profit
Average Return
+2.51%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 38.46% of your transactions generating a profit, with an average return of +2.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ARVN Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
13
17
23
17
24
Buy
4
2
2
0
2
Hold
1
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
20
26
18
26
Each month's total comprises the sum of three months' worth of ratings.
ARVN Financial Forecast
ARVN Stock Forecast FAQ
What is ARVN’s average 12-month price target, according to analysts?
Based on analyst ratings, Arvinas Holding Company’s 12-month average price target is $63.64.
What is ARVN’s upside potential, based on the analysts’ average price target?
Arvinas Holding Company has 246.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARVN a Buy, Sell or Hold?
Arvinas Holding Company has a consensus rating of Strong Buy which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
What is Arvinas Holding Company’s price target?
The average price target for Arvinas Holding Company is $63.64. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $110.00 ,the lowest forecast is $32.00. The average price target represents 246.43% Increase from the current price of $18.37.
The highest analyst price target is $110.00 ,the lowest forecast is $32.00. The average price target represents 246.43% Increase from the current price of $18.37.
What do analysts say about Arvinas Holding Company?
Arvinas Holding Company’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of ARVN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.